Eton Pharmaceuticals Inc (ETON)
3.59
-0.05
(-1.37%)
USD |
NASDAQ |
May 21, 16:00
3.59
0.00 (0.00%)
After-Hours: 20:00
Eton Pharmaceuticals Price to Book Value: 5.953 for May 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 20, 2024 | 6.036 |
| May 17, 2024 | 6.002 |
| May 16, 2024 | 6.052 |
| May 15, 2024 | 6.052 |
| May 14, 2024 | 6.019 |
| May 13, 2024 | 5.886 |
| May 10, 2024 | 5.687 |
| May 09, 2024 | 5.696 |
| May 08, 2024 | 6.168 |
| May 07, 2024 | 6.168 |
| May 06, 2024 | 6.218 |
| May 03, 2024 | 6.152 |
| May 02, 2024 | 6.218 |
| May 01, 2024 | 6.101 |
| April 30, 2024 | 5.803 |
| April 29, 2024 | 5.836 |
| April 26, 2024 | 5.720 |
| April 25, 2024 | 5.173 |
| April 24, 2024 | 5.322 |
| April 23, 2024 | 5.438 |
| April 22, 2024 | 5.388 |
| April 19, 2024 | 5.289 |
| April 18, 2024 | 5.073 |
| April 17, 2024 | 5.206 |
| April 16, 2024 | 5.289 |
| Date | Value |
|---|---|
| April 15, 2024 | 5.339 |
| April 12, 2024 | 5.670 |
| April 11, 2024 | 5.704 |
| April 10, 2024 | 5.687 |
| April 09, 2024 | 5.919 |
| April 08, 2024 | 5.720 |
| April 05, 2024 | 5.953 |
| April 04, 2024 | 5.903 |
| April 03, 2024 | 5.969 |
| April 02, 2024 | 6.102 |
| April 01, 2024 | 6.218 |
| March 31, 2024 | |
| March 28, 2024 | 6.224 |
| March 27, 2024 | 6.307 |
| March 26, 2024 | 6.324 |
| March 25, 2024 | 6.440 |
| March 22, 2024 | 6.573 |
| March 21, 2024 | 6.008 |
| March 20, 2024 | 5.809 |
| March 19, 2024 | 5.876 |
| March 18, 2024 | 5.776 |
| March 15, 2024 | 6.390 |
| March 14, 2024 | 7.402 |
| March 13, 2024 | 7.436 |
| March 12, 2024 | 7.303 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.897
Minimum
Sep 26 2022
154.04
Maximum
Dec 08 2020
14.25
Average
7.232
Median
Apr 19 2022
Price to Book Value Benchmarks
| Eli Lilly and Co | 59.59 |
| Evoke Pharma Inc | 1.105 |
| Outlook Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 20.95 |
Price to Book Value Related Metrics
| PE Ratio | 89.75 |
| PS Ratio | 2.700 |
| Price to Free Cash Flow | 23.11 |
| Price | 3.59 |
| Earnings Yield | 1.11% |
| Market Cap | 92.23M |
| Operating PE Ratio | 170.90 |
| Normalized PE Ratio | 89.75 |